The developmentally regulated shift from membrane to secreted mu mRNA production is accompanied by an increase in cleavage-polyadenylation efficiency but no measurable change in splicing efficiency.
about
hnRNP F influences binding of a 64-kilodalton subunit of cleavage stimulation factor to mRNA precursors in mouse B cellsTwo distant upstream regions containing cis-acting signals regulating splicing facilitate 3'-end processing of avian sarcoma virus RNA.Developmental regulation of immunoglobulin mRNA processing and the IgA response: establishing a paradigm.A nonimmunoglobulin transgene and the endogenous immunoglobulin mu gene are coordinately regulated by alternative RNA processing during B-cell maturationB-cell and plasma-cell splicing differences: a potential role in regulated immunoglobulin RNA processing.Non-snRNP U1A levels decrease during mammalian B-cell differentiation and release the IgM secretory poly(A) site from repressionHeterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) and elongation factor, RNA polymerase II, 2 (ELL2) are regulators of mRNA processing in plasma cellsUse of mutated self-cleaving 2A peptides as a molecular rheostat to direct simultaneous formation of membrane and secreted anti-HIV immunoglobulinsB-lineage regulated polyadenylation occurs on weak poly(A) sites regardless of sequence composition at the cleavage and downstream regionsAlternative poly(A) site selection in complex transcription units: means to an end?Regulation of poly(A) site use during mouse B-cell development involves a change in the binding of a general polyadenylation factor in a B-cell stage-specific manner.Exon size affects competition between splicing and cleavage-polyadenylation in the immunoglobulin mu geneRegulated immunoglobulin (Ig) RNA processing does not require specific cis-acting sequences: non-Ig RNA can be alternatively processed in B cells and plasma cells.Mechanisms controlling production of membrane and secreted immunoglobulin during B cell development.Splice site skipping in polyomavirus late pre-mRNA processing.Polypyrimidine tract binding protein prevents activity of an intronic regulatory element that promotes usage of a composite 3'-terminal exon.Characterization of a second secreted IgE isoform and identification of an asymmetric pathway of IgE assembly.Immunoglobulin heavy chain gene regulation through polyadenylation and splicing competition.Regulation of nuclear poly(A) addition controls the expression of immunoglobulin M secretory mRNA.The murine IgM secretory poly(A) site contains dual upstream and downstream elements which affect polyadenylationKnock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3'-UTRs.U1A inhibits cleavage at the immunoglobulin M heavy-chain secretory poly(A) site by binding between the two downstream GU-rich regions.Inducible nuclear factors binding the IgM heavy chain pre-mRNA secretory poly(A) site.Regulation of splicing is responsible for the expression of the muscle-specific 2a isoform of the sarco/endoplasmic-reticulum Ca(2+)-ATPase.Alternative poly(A) site utilization during adenovirus infection coincides with a decrease in the activity of a poly(A) site processing factorDistance-dependent processing of adeno-associated virus type 5 RNA is controlled by 5' exon definition.Alternative processing of the sarco/endoplasmic reticulum Ca(2+)-ATPase transcripts during muscle differentiation is a specifically regulated process.Balanced efficiencies of splicing and cleavage-polyadenylation are required for mu-s and mu-m mRNA regulation.
P2860
Q24548365-665F01ED-B099-4C34-8BCE-2FCD3E681AC7Q30452170-B8367751-A714-410E-B62B-DF047F1C6DADQ33723099-C4289091-54A0-41CD-A7FE-FEB9B0D5AADDQ33771608-F6DB1A12-BBC4-4474-BD81-81CC2DFA52F0Q34365384-61FFEABC-C1FA-45B2-AC99-839AFC1E0B17Q34366776-4245A5F6-274B-4BCC-A304-39B8F0096D42Q34418339-0E090CE5-6D55-47DB-BB12-BF52009844B7Q34500307-3529D789-8894-48B2-A5B3-1A9222B13FE3Q34620261-D12D1375-2DDB-435A-8773-26C8BD519CABQ34630891-80B99FDA-20A3-44CA-9481-5B6063A24043Q36555995-FBA75898-E9F1-44C7-B5E5-E3D1197E4466Q36642718-A068A6B0-F090-44FA-87A7-07ED1A4EE877Q36671278-E9C25CFA-CC7E-4601-BE2D-D66ED0058506Q36818995-E2C2AFD0-8A6E-49EB-AF28-B5AD963E5417Q36828187-300F61F6-5FCB-44E6-B075-297CD722AD5BQ37431966-60F0E0EE-FA75-45D8-9E30-F7C56D134CB2Q37654543-62FA5F54-9916-478D-8974-F2E1AE41826EQ37940409-7E918629-1A1A-4FB1-BE47-C242A2243208Q39646156-16737EE6-DB2F-466C-AF04-09CDA5E78873Q39720336-4AD6880D-B381-4C43-B94E-2BD45FCCBCD4Q40104739-1AAD6422-628C-4F83-B855-A40366DE9302Q40968429-0B58E39E-A5A9-41F5-A2EA-4D99643A6D65Q41147798-487A41FF-6AEA-488F-B486-3599973172CCQ41447005-5B09B9A3-C5EA-4334-B157-A5CC16C858CDQ41864496-65CE7732-AE55-484E-BBE7-36ECEABE94F3Q42108487-13C58C8D-0733-469A-87B8-9A51A80C4DFFQ42983119-DE3B4D7D-6B88-488E-BB5E-61544E38306AQ52234568-5B6E4FDF-3ABE-450E-ADAE-9F70F427559E
P2860
The developmentally regulated shift from membrane to secreted mu mRNA production is accompanied by an increase in cleavage-polyadenylation efficiency but no measurable change in splicing efficiency.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
The developmentally regulated ...... change in splicing efficiency.
@ast
The developmentally regulated ...... change in splicing efficiency.
@en
type
label
The developmentally regulated ...... change in splicing efficiency.
@ast
The developmentally regulated ...... change in splicing efficiency.
@en
prefLabel
The developmentally regulated ...... change in splicing efficiency.
@ast
The developmentally regulated ...... change in splicing efficiency.
@en
P2093
P2860
P356
P1476
The developmentally regulated ...... change in splicing efficiency.
@en
P2093
M L Peterson
P2860
P304
P356
10.1128/MCB.11.4.2324
P407
P577
1991-04-01T00:00:00Z